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Simple Summary: Porcine digestive peptides (PDP) are a coproduct of the heparin industry obtained
from the enzymatic hydrolysis of porcine intestinal mucosa. They have proven to be a valid substitute
for other high quality dietary protein sources for piglets, like spray-dried plasma (SDP), but knowledge
about their influence on intestinal function is still scarce. This study found that substituting soybean
ingredients with PDP and SDP to the diets of weaned piglets increased growth rate at 14 d post-weaning.
In addition, the combination of PDP with SDP increased the expression of certain genes related
to intestinal function in the jejunum, which suggests that this combination might have functional
properties that contribute to improving the intestinal health of the pigs, although more research is
needed to confirm it.
Abstract: This study was conducted to investigate the effects of dietary supplementation of porcine
digestible peptides (PDP), spray-dried plasma (SDP), or a combination of both, on growth performance
and the expression of genes related to intestinal function of weaned pigs. A total of 180 piglets (trial 1)
and 198 piglets (trial 2) were used to evaluate the partial substitution of soybean ingredients with 2%
SDP or 2% PDP (trial 1), and with 3% SDP or the combination of 1% SDP and 2% PDP (SDP-PDP;
trial 2) during the pre-starter period (0–14 days). The gene expression of 56 genes was quantified in
a qPCR platform in jejunum and ileum samples obtained from piglets 14 d after weaning (trial 2).
Piglets fed SDP, PDP and SDP-PDP had a higher body weight (BW), average daily gain (ADG) and
feed efficiency (G:F) than the soybean control on day 14 (p < 0.05). In addition, the combination
of SDP and PDP upregulated ten genes in jejunum samples (p < 0.05) related to intestinal function.
More research is needed to confirm that gene expression upregulation by PDP in combination with
SDP has an impact on intestinal function and to elucidate its underlying mechanisms.
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1. Introduction
Weaning is a stressful period for piglets as they have to deal with a change from sow milk to a less
digestible, plant-based dry solid diet that contains many ingredients that the pig has not eaten before [1].
One major consequence of weaning is a reduction in feed intake, which in turn causes a reduction in
the villi height in the small intestine [2] and a disruption of the gut microbiota ecosystem with a loss
of diversity [3]. After weaning, piglets are more susceptible to gut inflammatory problems and their
intestinal function can be affected. This often leads to post-weaning diarrhea and increased mucosal
permeability [4]. A strategy for helping piglets to reduce intestinal disturbances during this period is
to reduce the inclusion of less-digestible vegetal protein sources in their feed, like soybean ingredients,
and substitute them with high-quality digestible animal protein sources. Certain protein sources,
like spray-dried plasma (SDP) contain biologically active components that give them physiological
or regulatory functions beyond their nutritional value [5]. In particular, SDP has shown potential
for modulating the immune response, reducing intestinal mucosa inflammation and maintaining its
integrity [6–8].
Porcine digestible peptides (PDP) are a coproduct of the heparin industry and are obtained from
the enzymatic hydrolysis of porcine intestinal mucosa. Currently, PDP can be used in postweaning
diets as the cheapest alternative for SDP, fish meal and other sources of high-quality protein in terms of
preference and digestibility [9,10]. The ability of PDP to increase villus height suggests that they may
improve nutrient uptake [11]. However, there is no available literature exploring possible effects of
PDP on intestinal function when replacing major soy protein ingredients in the diet. In the present
study, in an initial trial we hypothesize that including PDP and SDP in a high crude protein (CP) diet
partially substituting a high content of soybean ingredients might improve piglet performance after
weaning (trial 1). In a second trial we also hypothesize that partially substituting soybean meal (SBM)
in weanling diets with SDP or a combination of SDP and PDP could improve piglet performance and
the expression of genes related to intestinal function (trial 2).
2. Materials and Methods
The experimental procedures used in the two trials were approved by the Ethical Committee
on Animal Experimentation of the Autonomous University of Barcelona (CEAAH 3817), and are in
full compliance with national legislation following the EU-Directive 2010/63/EU for the protection of
animals used for scientific purposes.
2.1. Animals, Housing and Diet
2.1.1. Trial 1
The first trial was conducted in the weanling unit of a commercial farm throughout
the pre-starter period (0–14 d post-weaning). A total of 180 male and female weaned commercial piglets
((Landrace × Large White) × Piétrain, weaned at 28 d) with a body weight (BW) of 7.5 ± SD 1.15 kg
were moved to the nursery unit. These animals were not given previous access to creep feed during
lactation. Piglets were distributed into two blocks according to initial BW (heavy piglets: 8.6 ± SD
0.03 kg; light piglets: 6.4 ± SD 0.02 kg). Each block contained 9 pens of 10 animals to which the three
experimental treatments were randomly assigned (6 pens or replicates/treatment). Each pen (3.2 m2 in
floor area) had a commercial non-lidded hopper (TR5, Rotecna, Agramunt, Spain) and a nipple waterer
to ensure ad libitum feeding and free water access.
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Treatments consisted of three different iso-protein pre-starter diets: a control diet (CON) with
a high content of soybean ingredients and two extra diets with partial replacement of the extruded
soybeans by 2% SDP (AP 820 P, APC Europe S.L., Granollers, Spain) or 2% PDP (Palbio 62SP, Bioiberica
S.A.U., Palafolls, Spain). The basal pre-starter diet was formulated to contain 2470 kcal of net energy
(NE)/kg, 19.5% CP/kg and 1.28% digestible Lys (Table 1) to meet the requirements for maintenance and
growth of newly weaned piglets [12]. Diets were presented in mash form and were fed ad libitum for
fourteen consecutive days. No antimicrobials or ZnO were used in the experimental diets.
2.1.2. Trial 2
The second trial was conducted in a different commercial farm throughout the pre-starter (0–14 d
post-weaning) and starter period (14–35 d post-weaning). A total of 198 male and female weaned
commercial crossing piglets ((Landrace × Large White) × Piétrain, weaned at 21 d) with a BW of
5.7 ± SD 0.60 kg were moved to the nursery unit without transport to be used in the trial. Piglets had
access to creep feed during lactation. Animals were distributed into two blocks according to initial
BW (heavy piglets: 6.3 ± SD 0.02 kg; light piglets: 5.1 ± SD 0.01 kg) and each block contained 9 pens
of 11 animals to which three experimental treatments were randomly assigned (6 replicates for each
treatment). Each pen (3 m2 in floor area) had a commercial non-lidded hopper (TR5, Rotecna) and
a nipple waterer to ensure ad libitum feeding and free water access. The different characteristics of
this farm compared to the farm of the first trial forced some changes to the experimental design of
the experiment.
Treatments consisted of three different iso-protein pre-starter diets: a CON diet with a high content
of SBM and two extra diets with partial replacement of the SBM by 3% spray-dried plasma (SDP;
AP 820 P, APC Europe S.L.) or a combination of 1% spray-dried plasma and 2% porcine digestible
peptides (SDP-PDP; Palbio 62SP, Bioiberica S.A.U.). The basal pre-starter diet was formulated to
contain 2470 kcal NE/kg, 20.5% CP/kg and 1.35% digestible Lys (Table 2) and to meet the requirements
for maintenance and growth of newly weaned piglets [13]. The pre-starter diets were fed ad libitum
for fourteen consecutive days and a common starter diet was also fed ad libitum from 15 to 35 d
post-weaning (Table 2). No antibiotics, alternative antimicrobials or ZnO were included in the diets.
2.2. Data and Sample Collection
Piglets were ear tagged and individually weighed at weaning (0 d) and 14 d post weaning in
trial 1 and at weaning (0 d), 7 d, 14 d and 35 d post-weaning in trial 2. Feed disappearance from each
hopper was measured throughout the experimental period. The average daily feed intake (ADFI),
average daily gain (ADG) and feed efficiency (G:F) were calculated for the experimental period.
One piglet per pen was sedated with a combination of zolazepam/tiletamine and xylazine, and was
euthanized with a pentobarbital injection on day 14 in trial 2. Portions of 0.5 cm of jejunum and ileum
tissues were collected at 30 cm and 1.3 cm from the ileo-cecal valve respectively. Intestinal sections
were rinsed in phosphate-buffered saline (PBS) and immediately snap frozen in 1 mL of RNAlater
(Deltalab, Rubí, Spain). Samples were stored at −80 ◦C until analysis.
2.3. Proximate Analysis of Diets
Diet proximate analyses from both trials were performed following the Association of Official
Agricultural Chemists methodology: dry matter (AOAC 934.01 [14]), ash (AOAC 942.05 [15]),
ether extract (AOAC 2003.05 [15]) and crude protein (AOAC 968.06 [16]). Neutral-detergent fiber was
determined according to the method of Van Soest et al. [17].
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Table 1. Composition of the experimental diets used on trial 1, % as fed basis.
Experimental Diets 1
Item CON SDP PDP
Ingredient, %
Maize 36.9 38.7 38.8
Wheat 16.0 16.0 16.0
Extruded Soybeans 15.0 11.4 11.2
Barley 13.0 13.0 13.0
Soybean meal 44% crude protein (CP) 6.8 6.8 6.8
Soybean protein concentrate 56% CP 5.6 5.6 5.6
Sweet milk whey 2.5 2.5 2.5
Spray-dried plasma 80% CP - 2.0 -
Porcine digestible peptides 62% CP - - 2.0
Mono calcium phosphate 1.34 1.37 1.30
Calcium carbonate 0.62 0.64 0.67
L-Lysine HCl 0.55 0.49 0.52
Salt 0.53 0.40 0.16
Vitamin-Mineral premix 2 0.40 0.40 0.40
DL-Methionine 0.27 0.23 0.57
L-Threonine 0.25 0.21 0.23
L-Valine 0.15 0.11 0.18
L-Tryptophan 0.09 0.08 0.10
Calculated composition
Net Energy (NE), kcal/kg 2470 2470 2470
Dry Matter, % 89.1 89.0 89.1
Ash, % 5.4 5.3 5.4
Crude Protein, % 19.5 19.7 19.5
Calcium, % 0.650 0.655 0.650
Total P, % 0.678 0.671 0.671
Digestible amino acids
Lys, % 1.280 1.280 1.280
Met, % 0.509 0.470 0.829
Cys, % 0.222 0.262 0.213
Met+Cys, % 0.768 0.768 1.078
Thr, % 0.832 0.832 0.832
Trp, % 0.282 0.282 0.282
Val, % 0.896 0.896 0.934
Analyzed composition
Dry Matter, % 89.1 88.8 88.8
Ether Extract, % 5.1 4.2 4.3
Neutral Detergent Fiber, % 10.5 10.2 10.0
Crude Protein, % 17.9 18.2 18.4
1 Experimental diets: CON: control diet; SDP: diet with 2% spray-dried plasma inclusion; PDP: diet with 2% porcine
digestible peptides inclusion. 2 Supplied the following per kg of diet: 7000 IU of vitamin A (acetate); 500 IU of
vitamin D3 (cholecalciferol); 250 IU of vitamin D (25-hydroxicholecalciferol); 45 mg of vitamin E; 1 mg of vitamin K3;
1.5 mg of vitamin B1; 3.5 mg of vitamin B2; 1.75 mg of vitamin B6; 0.03 mg of vitamin B12; 8.5 mg of D-pantothenic
acid; 22.5 mg of niacin; 0.1 mg of biotin; 0.75 mg of folacin; 20 mg of Fe (chelate of amino acids); 2.5 mg of Cu
(sulphate); 7.5 mg of Cu (chelate of glycine); 0.05 mg of Co (sulphate); 40 mg of Zn (oxide); 12.5 mg Zn (chelate of
amino acids); 12.5 mg of Mn (oxide); 7.5 of Mn (chelate of glycine); 0.35 mg of I, 0.5 of Se (organic); and 0.1 mg of
Se (inorganic).
2.4. Gene Expression Study by qPCR
Gene expression was quantified by RT-qPCR to study the expression of 56 genes in two intestinal
tissues in an Open Array Real-Time PCR Platform (Applied Biosystems, Waltham, MA, USA) by
the Servei Veterinari de Genètica Molecular at the Veterinary Faculty of the Universitat Autònoma de
Barcelona (Spain).
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The pre-amplified product was diluted 1:10 with 0.1× Tris-EDTA pH 8.0 and 6 µL was transferred
to 384-well plates. These were analyzed in duplicate in Taqman Open Array gene expression plates
custom-designed in a QuantStudio 12K Flex Real-Time PCR system (ThermoFisher Scientific, Waltham,
MA, USA). One sample was used as an inter-plate control to check the replication of results from
different plates.
Table 2. Composition of the experimental diets used on trial 2 (%, as fed basis).
Experimental Diets 1
Item CON SDP SDP-PDP Starter
Ingredients, %
Maize 29.68 32.53 32.11 29.79
Soybean Meal 47% crude protein
(CP) 25.82 20.6 21.34 21.34
Wheat 16 16 16 15
Barley 6.5 6.5 6.5 20
Dextrose 6.5 6.5 6.5 -
Sweet Milk Whey 6.5 6.5 6.5 -
Potato Protein 2.5 2.5 2.5 -
Lard 2.67 2.38 2.31 6.53
Di-calcium phosphate 1.72 1.77 1.67 1.56
Spray-dried plasma (80% CP) - 3 1 -
Porcine digestible peptides 62% PB - - 2 -
Salt 0.47 0.27 0.03 0.48
Vitamin-Mineral Premix 2 0.40 0.40 0.40 0.40
L-Lysine HCL (78) 0.46 0.39 0.39 0.51
DL-Methionine 0.27 0.24 0.25 0.25
L-Threonine 0.21 0.16 0.17 0.24
Calcium Carbonate 0.11 0.11 0.17 0.55
L-Valine 0.11 0.09 0.08 0.14
L-Tryptophan 0.08 0.07 0.09 0.07
Calculated composition
Net Energy (NE), kcal/kg 2470 2470 2470 2653
Ether Extract, % 4.69 4.43 4.39 8.61
Neutral Detergent Fiber, % 7.87 7.57 7.61 9.92
Crude Protein, % 20.51 20.50 20.50 18.50
Calcium, % 0.65 0.65 0.65 0.73
Total P, % 0.70 0.68 0.68 0.65
Digestible amino acids
Lys, % 1.350 1.350 1.350 1.230
Met, % 0.545 0.504 0.539 0.478
Met + Cys, % 0.810 0.810 0.810 0.720
Thr, % 0.878 0.878 0.878 0.780
Trp, % 0.297 0.297 0.297 0.264
Analyzed composition
Dry Matter, % 90.3 92.3 91.8 89.3
Ether Extract, % 4.6 4.3 4.1 8.4
Neutral Detergent Fiber, % 9.7 7.7 8.2 -
Crude Protein, % 19.7 18.7 19.6 17.7
1 Experimental diets: CON: control diet; SDP: diet with 3% spray-dried plasma inclusion; SDP-PDP:
diet supplemented with a combination of 1% spray-dried plasma and 2% porcine digestible peptides. 2 Supplied
the following per kg of diet: 7000 IU of vitamin A (acetate); 500 IU of vitamin D3 (cholecalciferol); 250 IU of vitamin
D (25-hydroxicholecalciferol); 45 mg of vitamin E; 1 mg of vitamin K3; 1.5 mg of vitamin B1; 3.5 mg of vitamin B2;
1.75 mg of vitamin B6; 0.03 mg of vitamin B12; 8.5 mg of D-pantothenic acid; 22.5 mg of niacin; 0.1 mg of biotin; 0.75
mg of folacin; 20 mg of Fe (chelate of amino acids); 2.5 mg of Cu (sulphate); 7.5 mg of Cu (chelate of glycine); 0.05
mg of Co (sulphate); 40 mg of Zn (oxide); 12.5 mg Zn (chelate of amino acids); 12.5 mg of Mn (oxide); 7.5 of Mn
(chelate of glycine); 0.35 mg of I, 0.5 of Se (organic); and 0.1 mg of Se (inorganic).
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2.5. Open Array Design
A list of 56 genes related to intestinal health were selected according to the bibliography [18–31]
and included: (1) genes participating in the barrier function (OCLN, ZO1, CLDN1, CLDN4, CLDN15,
MUC2, MUC13 and TFF3); (2) genes that play an important role in the immune response, such as
pattern recognition receptors, cytokines, chemokines and stress proteins (TLR2, TLR4, IL1B, IL6, IL8,
IL10, IL17A, IL22, IFNG, TNF, TGFB1, CCL20, CXCL2, IFNGR1, HSPB1, HSPA4, REG3G, PPARGC1A,
FAXDC2 and GBP1); (3) genes coding for enzymes and hormones implicated in the digestion process
(GPX2, SOD2, ALPI, SI, DAO1, HNMT, APN, IDO1, GCG, CCK, IGF1R and PYY); (4) genes involved in
nutrient transport (SLC5A1, SLC16A1, SLC7A8, SLC15A1, SLC13A1, SLC11A2, MT1A, SLC30A1 and
SLC39A4); (5) genes involved in stress response (CRHR1, NR3C1 and HSD11B1); and (6) four reference
genes (ACTB, B2M, GAPDH and TBP).
Primers were designed spanning exon-exon boundaries or at different exons using PrimerExpress
2.0 software (Applied Biosystems) for 55 genes. The IL8 gene primer was pre-designed by the company
due to its complexity (Table A1). Possible residual genomic DNA amplification and primer dimer
formation were controlled. Finally, a customized open array panel containing 56 genes was obtained.
2.6. RNA Extraction and cDNA Preparation
Total RNA was obtained from 100 mg of frozen intestinal tissues with the RiboPure kit
(Ambion, Austin, TX, USA) following the manufacturer’s protocol. RNA concentration and purity was
calculated with a NanoDrop ND-1000 spectrophotometer (NanoDrop products, Wilmington, DE, USA).
RNA integrity was checked with Agilent Bioanalyzer-2100 equipment (Agilent Technologies, Santa Clara,
CA, USA) following the producer’s protocol. One microgram of total RNA was reverse-transcribed into
cDNA in a final volume of 20µL. The High-Capacity cDNA Reverse Transcription kit (Applied Biosystems)
and random hexamer primers were used, and the following thermal profile was applied: 25 ◦C, 10 min;
37 ◦C, 120 min; 85 ◦C, 5 s; 4 ◦C hold. A total of 25 ng of cDNA sample was pre-amplified using a 2×
TaqMan PreAmp Master Mix and a 0.2× Pooled Taqman Gene Expression Custom Assays in a final
volume of 10 µL. The thermal cycling conditions for the pre-amplification reactions were 10 min at 95 ◦C;
14 cycles of 15 s at 95 ◦C and 4 min at 60 ◦C; and a final step of 10 min at 99 ◦C. The pre-amplified cDNA
product was stored at −20 ◦C until use.
2.7. Gene Expression Data Analysis
Gene expression data were collected and analyzed using the ThermoFisher Cloud software 1.0
(Applied Biosystems) applying the 2−∆∆Ct method for relative quantification and using the sample
with the lowest expression as a calibrator. Some parameters were adjusted: the maximum cycle
relative threshold allowed was 26, amplification score < 1.240, quantification cycle confidence > 0.8
and the maximum standard deviation allowed between duplicates was set at <0.38. Samples that
did not fit these requirements or had an inconclusive amplification status were deleted. Relative
quantification values were checked for normalization by a log10 transformation, and all the statistical
analyses were performed with R 3.4.3 software [32] and Bioconductor [33]. We carried out a one-way
ANOVA and calculated the Benjamini–Hochberg false discovery rate (FDR q-value) to control multiple
p-values [34], setting an upper bound for the expected proportion of false significant tests, that is,
false significant treatment differences in mean expression levels between treatments. Pairwise post hoc
treatment comparisons were carried out using Tukey’s honest significant difference test [35]. Statistical
differences between results for the treatments were identified at p-values and q-values under 0.05 for
the ANOVA and Tukey’s analysis and for the FDR, respectively.
A principal component analysis (PCA) was performed with samples as cases and gene
log10-expressions as variables. The function PCA of the FactoMiner R-library [36] was used for dimension
reduction and visualization in the first two principal dimensions. The variables factor map was restricted
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to genes showing cos2-qualities over 0.45 and significant differences. Finally, the heatmap visualization
method was used to obtain double clustering both for genes (with a correlation-based distance:
d = (1− r)/2, (1)
where d is the distance and r is the correlation coefficient, and the complete linkage hierarchical
clustering) and for samples (with Euclidean distance and Ward’s D2 method). These methods were
chosen based on the following: the Euclidian distance between two samples adds all the squared
differences in the log-expression level of them in each gene, and then the Ward’s D2 linkage method
uses the Euclidean squared-distance to cluster in a way that minimizes the increment of the variance
into the resulting clusters. Correlation based distance is preferred for obtaining the gene clusters
because the expression levels in different genes may not be comparable (see Murtagh and Legendre [37]
for Ward’s method and Everitt [38] for clustering methods). The function heatmap.2 in the R-library
gplots was used [39].
2.8. Performance Data Statistical Analysis
Production performance data were analyzed with ANOVA using the generalized linear model
procedure of the statistical package SAS (version 9.4, SAS Inst. Inc., Cary, NC, USA). Normality
and homoscedasticity were checked with Shapiro–Wilk test using the univariate procedure and
Levene’s test using the generalized linear model procedure, respectively. Data were analyzed taking
the experimental treatment and the block of weight as the main factors. Their corresponding interaction
was also included in the model. The statistical unit was the pen of 10 pigs in trial 1 and the pen of 11
pigs in trial 2. The results are presented as least square means taking into account the Tukey adjustment.
The level of significance considered was α = 0.05.
3. Results
3.1. Growth Performance
The productive performance of piglets during the first two weeks after weaning (trial 1) is
summarized in Table 3. Animals fed SDP and PDP showed higher BW, ADG and G:F (p < 0.05) than
piglets in the control group.
Table 3. Effect of the experimental treatments on growth performance of piglets in trial 1.
Experimental Diets 3
Item 2 CON SDP PDP SEM p-Value 1
BW, day 0, g 7505 7517 7534 12.0 0.241
day 14, g 9438 b 10,381 a 9990 a 138.9 0.001
ADFI 0–14 d, g/d 236 b 295 a 250 b 11.3 0.002
ADG 0–14 d, g/d 138 b 205 a 175 a 11.8 0.002
G:F 0–14 d 0.554 b 0.695 a 0.700 a 0.0413 0.034
1 p-values come from the ANOVA test. 2 BW: body weight; ADFI: average daily feed intake; ADG: average daily
gain; G:F: feed efficiency. 3 Experimental diets: CON: control diet; SDP: diet with 3% spray-dried plasma inclusion;
SDP-PDP: diet supplemented with a combination of 1% spray-dried plasma and 2% porcine digestible peptides.
a,b Different letters in the same row indicate significant statistical mean differences in the two diets (Tukey’s test
p-value < 0.05).
For trial 2, the productive performance results are shown in Table 4. Piglets of the SDP and
SDP-PDP group showed greater BW, ADG and G:F than CON piglets at 14 d (p < 0.05). Although
a numeric difference in BW was observed at 35 d between the supplemented animals and the CON
group, no significant differences in BW, ADG or G:F were observed.
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Table 4. Effect of the experimental treatments on growth performance of piglets in trial 2.
Experimental Diets 3
Items 2 CON SDP SDP-PDP SEM p-Value 1
BW, day 0, g 5724 5720 5721 46.9 0.859
day 7, g 5956 b 6344 a 6254 ab 88.3 0.023
day 14, g 7165 b 7894 a 7871 a 152.7 0.008
day 35, g 15,270 16,252 15,960 460.3 0.335
ADFI, 0–14 d, g 267 282 283 5.96 0.139
14–35 d, g 483 508 525 25.9 0.532
ADG, 0–14 d, g 103 b 155 a 153 a 10.7 0.007
14–35 d, g 364 398 382 22.0 0.571
G:F, 0–14 d 0.380 b 0.548 a 0.540 a 0.0383 0.046
14–35 d 0.761 0.782 0.732 0.0501 0.840
1 p-values come from the ANOVA test. 2 BW: body weight; ADFI: average daily feed intake; ADG: average daily
gain; G:F: feed efficiency. 3 Experimental diets: CON: control diet; SDP: diet with 3% spray-dried plasma inclusion;
SDP-PDP: diet supplemented with a combination of 1% spray-dried plasma and 2% porcine digestible peptides.
a,b Different letters in the same row indicate significant statistical mean differences in the two diets (Tukey’s test
p-value < 0.05).
3.2. Intestinal Mucosa Gene Expression Values
After performing qPCR of the intestinal tissue, 37 genes were detected as expressed in jejunum
tissue and 27 genes in ileum tissue from the 54 target genes initially included in the open array panel.
The conservation of one tissue sample from the jejunum and seven from the ileum was affected and
amplification was not possible. Gene expression results of the ileum tissue were not considered due to
the high amount of lost samples of this intestinal section.
The results of the analysis of gene expression in the jejunum intestinal tissue (trial 2) are shown in
Table 5. Although only two genes showed statistical differences between groups (p < 0.05, q < 0.05),
the other 8 genes showed a trend of being modified by the diets (p < 0.05, q < 0.2). The CLDN15 and
TFF3 genes from the barrier function group and the SLC11A2/DMT1 gene from the nutrient transport
group showed a tendency to higher expression for the SDP-PDP treatment compared to the CON
treatment (p < 0.05). From the immune response functional group, the SDP-PDP group showed a trend
of having higher expression levels in three genes: GBP1 compared to the SDP group, IFNGR1 compared
to the CON group, and TLR4 compared to the other two groups (p < 0.05). Finally, the SDP-PDP group
had a higher expression level than the CON and SDP groups in two enzyme-coding genes (HNMT and
APN) that was only significant for HNMT (q < 0.05). The gene coding for a protein that metabolizes
oxidation products, SOD2, also showed a significant increase when comparing the SDP-PDP group
with the CON and SDP groups.
A PCA was carried out to determine the correlation in the gene expression values among samples
distributed in the three diet groups (Figure 1). The sample identifier numbers are represented in
the individual factor map (a) and are colored according to the diet assigned to each sample. The variables
factor map (b) shows which genes are correlated along the samples. The 2D representation preserves
60% of the total variance (61.27). The results show a correlation in the gene expression pattern. In this
tissue, eight of the nine significant genes (APN, HNMT, SLC11A2, CLCN15, IFNGR1, TLR4, GBP1 and
SOD2) are well represented in 2D (long arrows) and all of them fall in the first quadrant. Furthermore,
the blue colored samples in the SDP-PDP group fall in the same quadrant or near to it, which indicates
medium to high expression levels. Therefore, these plots clearly show a relationship between the highest
expression levels in these significant genes and the SDP-PDP diet group. The CON and SDP groups
are mixed and do not show high expression values.
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Table 5. Effect of the experimental treatments on relative gene expression on jejunum mucosa after pre-starter period. Gene expression values are presented as ratios
of cycle relative threshold value for each gene normalized to that of the reference sample. p-Values come from the ANOVA test and FDR is the false discovery rate.
Function Genes 1
Experimental Diets 2
Contrast Statistic p-Value q-Value (FDR)
CON SDP SDP-PDP
Barrier function
CLDN15 0.51 b 0.81 ab 1.05 a 4.984 0.027 0.139
TFF3 1.15 b 1.07 ab 1.83 a 4.290 0.035 0.145
Immune response
TLR4 1.54 b 1.31 b 2.86 a 8.052 0.005 0.059
GBP1 2.40 ab 1.80 b 4.20 a 5.711 0.015 0.127
IFNGR1 0.69 b 0.74 ab 1.10 a 4.661 0.028 0.139
Nutrient transport SLC11A2/DMT1 0.37 b 0.71 ab 1.24 a 3.862 0.046 0.169
Enzyme/Hormone HNMT 0.86
b 0.91 b 1.56 a 14.111 4 × 10−4 0.015
APN 1.59 b 1.40 b 3.40 a 4.577 0.030 0.139
Oxidation SOD2 1.04 b 0.95 b 1.71 a 11.030 0.001 0.022
1 Genes: CLDN15: claudin 15; TFF3: trefoil factor 3; SLC11A2/DMT1: solute carrier family 11 member 2/divalent metal transporter 1 (DMT1); TLR4: Toll like receptor 4; GBP1: guanylate
binding protein; IFNGR1: interferon gamma receptor 1; HNMT: histamine N-methyltransferase; APN: alanyl aminopeptidase; SOD2: superoxide dismutase 2. 2 Experimental diets:
CON: control diet; SDP: diet with 3% spray-dried plasma inclusion; SDP-PDP: diet supplemented with a combination of 1% spray-dried plasma and 2% porcine digestible peptides (2%).
a,b Different letters in the same row indicate significant statistical mean differences in the two diets (Tukey’s test p-value < 0.05).
Animals 2020, 10, 2368 10 of 21
















Figure 1. Principal component analysis (PCA): (a) Samples’ picture from jejunum (individuals factor map); (b) gene expressions arrow diagram from jejunum 
(variables factor map); CON: control diet; SDP: diet with 3% spray-dried plasma inclusion; SDP-PDP: diet supplemented with a combination of 1% spray-dried 
plasma and 2% porcine digestible peptides. Samples are labeled with different colors depending on the treatment, and the gene expressions arrows diagram on the 










i r . Principal co ponent analysis (PCA): (a) Sa ples’ picture fro j j (i i i uals factor ap); ( ) e r ssi s rr i r fr j j
( i l f t r ap); CON: control diet; SDP: diet with 3% spray-dried plasma inclusion; SDP-PDP: diet supplemented with a combination of 1% spray-dried plasma
and 2% porcine digestible peptides. Samples are label d with different colors depen ing on the treatment, and the gene expressions arrows diagram on the rig t.
Only those genes with p < 0.05 and h ving a long arrow have been d picted. Each arrow color indicates a different func ional group. Trial 2.
Animals 2020, 10, 2368 11 of 21
A heatmap was also made in order to observe overall similarities among the gene expression
profiles of the animals (Figure 2). On the heatmaps, the samples from the SDP-PDP treatment tend
to group in pairs with others in the same group in the first step (the shortest branches). In addition,
most SDP-PDP samples fall on one side of the dendrogram, the side with the highest number of red
pixels in many genes, indicating a higher level of expression of these genes within the SDP-PDP group.
Clustering of genes does not show any evidence of an association by functional group.
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Figure 2. Heatmap representing the gene expression of each sample from jejunum in each gene in trial 2.
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rows and samples in columns. Samples are labeled with different colors representing every treatment
and genes depending on its functional group.
4. Discussion
This study found that substituting soybean ingredients with either 2–3% PDP, SDP or both to
the diets of weaned piglets increased growth rate early after weaning. There are two main reasons
that could be suggested and contribute to the observed results, such as the reduction of the negative
impact of the soybean ingredients and the beneficial effects of the PDP and SDP. Unfortunately,
our experimental design does not allow discrimination between them. The diets in the present study
were formulated to contain a high inclusion of soybean ingredients, such as soybean meal 44% or 47%
CP, extruded soybeans and soybean protein concentrate 56% CP. The β-sheet structures present in
the secondary structure of raw legume proteins and the intermolecular β-sheet aggregates derived
from heating are negatively correlated with feed digestibility values [40]. The β-sheet structures
represent more than 30% of the secondary structure of soybean seeds, while they represent less than
10% in the ingredients of animal origin [41]. Consequently, the flow of protein into the distal parts of
the gastrointestinal tract tends to be faster when more soybean ingredients are included, which promotes
protein fermentation and selective growth of proteolytic bacteria [41]. Furthermore, soybeans contain
anti-nutritional factors, such as antigens, trypsin inhibitors and lectins, which can produce digestive
disorders and reduce nutrient availability [42,43]. The consequences of high inclusion of soybean
ingredients, aggravated by the situation of post-weaning anorexia, can lead to intestinal disorders,
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such as post-weaning diarrhea [2,44]. This can negatively affect the animal growth performance.
In the present study, the reduction of soy ingredients accounts for 3–5% of the diet, being replaced by
either SDP, PDP, or both. In contrast, proteins of animal origin as well as animal protein hydrolysates
have higher palatability than vegetal proteins [10,45,46], which can translate into an increased feed
intake after weaning.
The substitution of soybean ingredients with SDP improved the productive performance at
the end of pre-starter period of both trials. The results reported herein are similar to other studies that
showed that SDP improved performance, especially when piglets were challenged with experimental
infection and did not receive in-feed medication [47]. Spray-dried plasma is commonly used because
it can stimulate feed intake due to its palatability [48], as observed in trial 1. Its beneficial effects are
explained by the preservation of blood immunoglobulins, growth factors and bioactive peptides or
compounds during the spray-drying process. These components can interact with the gut-associated
lymphoid tissue [49], therefore preserving the small intestinal barrier function and reducing intestinal
inflammation and damage [6].
Consumption of feed containing the hydrolysates, PDP or SDP-PDP, enhanced the productive
performance of piglets compared to their corresponding control group at the end of the pre-starter
period, and these groups were equivalent to the SDP group. This result is in accordance with other
authors who also obtained similar growth performance by feeding PDP and SDP in early-weaned
piglets [50]. Some research data have shown improved growth performance, feed intake and efficiency
of animals fed PDP compared to other high-quality protein sources like fish meal [45]. Other studies
found that the inclusion of PDP in weanling diets improved villus height of the small intestine
compared to some sources of intact protein like SDP [51] or fish meal [11], which can be considered
a good indicator of nutrient uptake. Part of the beneficial effects of PDP on growth performance
could be due to its content of short-chain peptides that are more easily absorbed by pigs than intact
proteins [52] or even free amino acids [53].
This is the first study performed using gene expression to provide some inputs about the effects
of PDP on intestinal function. The outcome of the PCA individual factor map of the gene expression
shows that the factorial scores of the SDP-PDP group tended to be closer to each other and more
separate from the CON and SDP group scores. In addition, the correspondence of most of the arrows
representing the significant genes in the PCA variables map and most of the samples in the SDP-PDP
group in a similar position indicates that there is a relationship between the higher expression levels
in these genes and the differences that the SDP-PDP group showed from the CON and SDP groups.
Heatmap representation also helped to visualize a partial clustering of the samples from the SDP-PDP
treatment in the jejunum and ileum. In line with this, the statistical ANOVA and Tukey’s test showed
a stronger effect of the SDP-PDP diet than SDP with respect to the CON diet. Although all results
agree, ANOVA and Tukey’s test deal with mean treatment values while heatmaps and PCA-plots
reflect individual performance. The combination of inferential treatment comparison techniques
(ANOVA and Tukey, essentially) and powerful exploratory methods (PCA and heatmap) provide
a clearer and dual (individuals and genes) idea of the differences in gene expression.
Proteins coded by the genes analyzed in the current study participate in the barrier function of gut
cells, in nutrient transport in the mucosa, in digestion, in the immune response and in the metabolization
of oxidation products.
Some trends in the jejunum gene expression due to diets may indicate a potentiation of the epithelial
structure by SDP-PDP, because, for example, the TFF3 gene participates in epithelial restitution and
maintenance of intestinal mucosa integrity [24]. However, the CLDN15 gene, which expression
was also modified, codes for a pore-forming protein [22], which is important for the normal-sized
morphogenesis of the small intestine [25].
Diets also had an effect on the expression in the jejunum of genes related to the immune response
and metabolization of oxidation products. Again, the SDP-PDP diet showed more changes than
the SDP diet alone. Expression of immune response genes TLR4, IFNGR1 and GBP1 showed a trend to
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increase in the SDP-PDP group, TLR4 compared to the CON and SDP groups; IFNGR1 compared to
the CON group and GBP1 compared to the SDP group.
TLR4 is a receptor involved in the recognition of lipopolysaccharide, a major cell wall component
of Gram-negative bacteria [19], and IFNGR1 is part of the receptor that mediates the biological effects
of IFN-γ [54]. The TLR4 and IFNGR1 genes have been reported to be upregulated in animals under
stress and with infectious conditions in order to activate the innate immune response and fight against
pathogens properly [24,28,55]. Thus, the tendency for upregulation of TLR4 and IFNGR1 might
suggest that piglets fed with SDP-PDP seem to be more prepared for controlling infective processes and
other intestinal challenges that can occur during the weaning period. In addition, GBP1 is a GTPase
that regulates the inhibition of proliferation and invasion of endothelial cells. It protects against
epithelial apoptosis induced by inflammatory cytokines and subsequent loss of the barrier function [27].
Upregulation of GBP1 by the SDP-PDP diet, although without being statistically significant, is probably
related to IFNGR1 upregulation because GBP1 expression is strongly induced by IFN-γ [27], although
an upregulation of IFN-γ was not observed in this study.
Focusing on nutrient transport, only an up-regulatory trend in the expression of the SLC11A2/DMT1
gene was found in animals fed with the SDP-PDP combination compared to the CON group.
The divalent metal transporter (SCL11A2/DMT1) is located on the apical surface of the enterocyte
and is involved in the intestinal Fe uptake [18]. SLC11A2/DMT1 gene expression is upregulated in
circumstances of low Fe intake [26] and hyperglycemia conditions [56]. We have no evidence of
differences in the Fe content or glycemic levels among experimental diets; therefore, the reason why
the SDP-PDP treatment influenced the expression of SLC11A2/DMT1 should be researched further.
The enzyme-coding gene HNMT was upregulated and the gene APN showed a trend to increase
due to the SDP-PDP diet. Kröger et al. [31] reported that high dietary inclusion of fermentable CP
increased the HNMT expression in the colon, which is a histamine-degrading enzyme. They determined
that the histamine catabolism activity of HNMT counter-regulated the increased production of this
biogenic amine, reducing the fecal score of the piglets fed with a high fermentable CP diet. Considering
that all diets had an elevated CP level, an increase in this enzyme could show that SDP-PDP was
attenuating the inflammatory effects of histamine more efficiently than other groups. On the other hand,
APN is a Zn-dependent enzyme that takes part in the final digestion of peptides [56]. Its upregulation
in the small intestine has been documented with products considered beneficial for intestinal health,
such as the probiotic Lactococcus lactis [23]. Therefore, its increase due to the SDP-PDP diet may also be
considered a positive physiological change.
Regarding the antioxidant defense mechanisms, we observed here that the expression of the SOD2
gene was also increased in the SDP-PDP group compared to both the SDP and CON groups.
This mitochondrial enzyme is considered the first defense against reactive oxygen species (ROS)
formed during normal cell metabolism [30]. Elimination of ROS by SOD2 can be considered as
an anti-inflammatory effect due to the important role that ROS plays in triggering and promoting
inflammation [57]. As well as the TLR4 gene, expression of SOD2 is stimulated by lipopolysaccharides
but cytokines or ROS can also upregulate it [58]. Thus, changes in SOD2 gene expression can be derived
from the TLR4 upregulation also induced by the SDP-PDP intervention.
The gene expression results of this trial might indicate that the combination of PDP and SDP had
some effects on intestinal function, although most of the differences found among treatments only
could be considered as a trend (p < 0.05, q < 0.2). First of all, the tendency for upregulation of TFF3 and
CLDN15 could be considered a potentiation of the epithelial structure of the gut, which would be related
to the increase of villi height observed in previous studies with PDP [51]. Secondly, we could speculate
that animals fed PDP-SDP might be more prepared for controlling infective processes and defending
against other hazardous processes due to the up-regulatory trend in the expression of the immune
response genes (TLR4, IFNGR1 and GBP1) and the upregulation of genes related to the degradation of
toxic products of metabolism (SOD2 and HNMT). In addition, the trend to increase the expression of
the APN gene could suggest an improvement in the digestion of protein. The underlying mechanisms
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that produced these effects are still unknown and the literature exploring possible functional effects of
PDP is still scarce. More research is needed to confirm that gene expression upregulation by PDP in
combination with SDP has an impact on intestinal function and to elucidate the underlying mechanisms
that are responsible of these effects. Furthermore, it might be interesting to investigate if the effects on
gene expression observed in this study are only attributable to the addition of PDP or if it is a synergy
of PDP with SDP that is producing the effects, as SDP alone did not show them.
5. Conclusions
The present study suggests that substituting soybean products with animal protein sources like
PDP or SDP increases growth performance of weanling piglets at the end of the pre-starter period.
In addition, it indicates that PDP can substitute or complement SDP because it showed the same
effect on the growth performance of the piglets during this period. Furthermore, changes in the gene
expression of the jejunum produced by the SDP-PDP diet suggest that this treatment might be able to
produce beneficial effects in the epithelial structure of the gut, in the defensive capacity of the intestine
against threats and the digestion of proteins. More research is needed to confirm that gene expression
upregulation by PDP in combination with SDP has an impact on intestinal function and to elucidate
the underlying mechanisms that are responsible for these effects.
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Appendix A
Table A1. List of primers used for the analyses of gene expression of the 56 genes by Open Array Real-Time PCR custom designed.
Gene Name Primer Forward (5′-3′) Primer Reverse (5′-3′) Probe (5′-3′)
OCLN Occludin CAGGTGCACCCTCCAGATTG CAGGCCTATAAGGAGGTGGACTT TGACATCAGCCATGTCAT
ZO1 Zonula occludens 1 GCTATGTCCAGAATCTCGGAAAA TGCTTCTTTCAATGCTCCATACC TCACCATCTTTTTACAACTAC
CLDN1 Claudin-1 CTTCGACTCCTTGCTGAATCTGA CTTCCATGCACTTCATACACTTCAT ACAGCACTTTGCAAGC
CLDN4 Claudin-4 CCTCCGTGCTGTTCCTCAA GAGGCACAAGCCCAGCAA CCTTGTGGCACTTTG
CLDN15 Claudin-15 GCTATCTCCTGGTATGCCTTCAA GGGACTTCCACACTCCTTGGT ACTTCTTCGACCCCTTGTA
MUC2 Mucin 2 AAGGACGACACCATCTACCTCACT GGCCAGCTCGGGAATAGAC CATGGTCAGCACCCCG
MUC13 Mucin 13 CAGTGGAGTTGGCTGTGAAAAC ATCAAGTTCTGTTCTTCCACATTCTTG TCCTCTCATTAAGATCAAAC
TFF3 Trefoil factor 3 AGAACCTGCCCGTGACCAT CACACTGGTTCGCCGACAG AGGCCAGGATGTTCT
TLR2 Toll-like receptor 2 CTCTCGTTGCGGCTTCCA AAGACCCATGCTGTCCACAAA CAAGGTCAACTCTCTG
TLR4 Toll-like receptor 4 CATCCCCACATCAGTCAAGATACT TCAATTGTCTGAATTTCACATCTGG ACAGCAATAGCTTCTCCA
IL1B Interleukin 1 beta GGTGACAACAATAATGACCTGTTATTTG GCTCCCATTTCTCAGAGAACCA ATGAAGTGCTGCACCC
IL6 Interleukin 6 CCAATCTGGGTTCAATCAGGAG ACAGCCTCGACATTTCCCTTATT AGATATACCTGGACTACCTC
IL8 Interleukin 8 GGAAAAGTGGGTGCAGAAGGT GAGAATGGGTTTTTGCTTGTTGT TACAGATATTTTTGAAGAGAACT
IL10 Interleukin 10 TGAGGCTGCGGCGCT GAGCTTGCTAAAGGCACTCTTCA AACAAGAGCAAGGCCGT
IL17A Interleukin 17 CCAGACGGCCCTCAGATTAC ATCTTCCTTCCCTTCAGCATTG CCATGGACTCTCCAACG
IL22 Interleukin 22 TGTTCCCCAACTCTGATAGATTCC GTTGTTCACATTTCTCTGGATATGCT AGCTAAGCCAATGCCGTAT
IFNG Interferon gamma TGACTTTGTGTTTTTCTGGCTCTT CACTCTCCTCTTTCCAATTCTTCAA ATCCTAAAGGACTATTTTAAT
TNF Tumor necrosisfactor alpha CACCACGCTCTTCTGCCTACT GACGGGCTTATCTGAGGTTTGA CAAGGACTCAGATCATCGT
TGFB1 Transforming growthfactor beta 1 GCGGCAGCTCTACATTGACTT GACCTTGCTGTACTGAGTGTCTAGG CCATGCCAATTTCTGCCT
CCL20 Chemokine (C-C motif)ligand 20 GACCATATTCTTCACCCCAGATTT CACACACGGCTAACTTTTTCTTTG ATCAATGCAATCATCTTT
Animals 2020, 10, 2368 16 of 21
Table A1. Cont.
Gene Name Primer Forward (5′-3′) Primer Reverse (5′-3′) Probe (5′-3′)
CXCL2 Chemokine (C-X-C motif)ligand 2 CATGGTGAAGAAAATCATCGAGAA GCCAGTAAGTTTCCTCCATCTCTCT AACAAGAGCAGTGCCAAC
IFNGR1 Interferon gammareceptor 1 CATGTTACCCAAATCTTTGCTGTCT CAGTATGCACGCTTGAAATTGTC ATATATATCACCCATCACCTACC
HSPB1 Heat shock protein 27 CGAGGAGCTGACGGTCAAG GCAGCGTGTATTTTCGAGTGAA ACGGCTTCATTTCCCGGT
HSPA4 Heat shock protein 70 TCAATTGCCTGCGATTAATGAA GAATGCCCCATGTCTACAAAAAC CAGTTGCTCTTGCATATG






FAXDC2 Fatty acid hydrolasedomain containing 2 CCATGACTACCACCATCTCAAGTT GCAGGATCGTGTGTCTCTCGTA TGTTCAAGCAGACCAAG
GBP1 Guanylate bindingprotein 1 AGAATCCATCACAGCAGACGAGTA CGGATACAGAGTCGAGGCAGGTTAA TCAAGCTTAAGAAGGGTACCAG
GPX2 Glutathione peroxidase 2 CAACCAATTTGGACATCAGGAG GGGTAAAGGTGGGCTGGAAT AGATCCTGAACAGCCTCA
SOD2 Superoxide dismutase GGGTTGGCTCGGTTTCAA CATGCTCCCACACGTCGAT CTGCAAGGAACAACAGGTCT
ALPI Intestinal alkalinephosphatase ATGTCTTCTCTTTTGGTGGCTACA GGAGGTATATGGCTTGAGATCCA AAGCTCCGTTTTTGGCCT
SI Sucrase-isomaltase CGACCCCTTTTGCATGAGTT AAGGCTGGACCCCATAGGAA TTTAATGAAAAGCCAACCTG
DAO1 Diamine oxidase GGAACCAACAGACCTTCAACTATCTC TTCGGAATCCCAGGACCAT CCGGACCCTTACTGGAAA
HNMT HistamineN-methyltransferase TGTTGAACCAAGTGCTGAACAAAT ACTTTATGTTCTCGAGGTTTGATGTCTT ACCAAGTACAAAGAGCTT
APN Aminopeptidase-N AGGGCAACGTCAAAAAGGTG GTCAAAGCATGGGAAGGATTTC ACACAGATGCAGTCTACAG
IDO1 Indoleamine 2,3dioxygenase TTGGCAAATTGGAAGAAAAAGG CCGGAAATGAGAAGAGAATATCCAT CCAGTGGGCCCATGACTTAC
GCG Glucagon AGGCGTGCCCAGGATTTT CATCGTGACGTTTGGCAATG CACCAAGAGGAACAAGAA
CCK Cholecystokinin CAGCAGGCTCGAAAAGCAC AATCCATCCAGCCCATGTAGTC CAGCCACAGAATAAGTGA
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Table A1. Cont.
Gene Name Primer Forward (5′-3′) Primer Reverse (5′-3′) Probe (5′-3′)
IGF1R Insulin-like growth factor1 receptor CCGACGCGGCAACAAC TCAGGAAGGACAAGGAGACCAA CTACGTGAAGATCCGCCA
PYY Peptide tyrosine tyrosine CAGAGGTATGGGAAACGTGACA CCTTCTGGCCACGACTTGAC CAAACTGCTCTTCCCTGAA
SLC5A1




SLC16A1 Monocarboxylatetransporter 1 CCTTGTTGGACCTCAGAGATTCTC CCAGTATGTGTATTTATAGTCTCCGTATATGTCCCACCACTTTTAGGTCGTC
SLC7A8
Solute carrier family 7
(amino acid transporter



















MT1A Metallothionein 1A TGAATCCGCGTTGCTCTCT CAGGAGCAGCAGCTCTTCTT ACGTGCAAAACCTGCAGA
SLC30A1









CRHR1 Corticotropin releasinghormone receptor 1 CAGGGCCCCATGATATTGG CCGGAGTTTGGTCATGAGGAT CTGATCAACTTTATCTTCC
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Table A1. Cont.
Gene Name Primer Forward (5′-3′) Primer Reverse (5′-3′) Probe (5′-3′)
NR3C1 Glucocorticoid receptor GGCAATACCAGGATTCAGGAACT CCATGAGAAACATCCATGAATACTG TGACCAAATGACCCTCCT
HSD11B1 Hydroxysteroid (11-beta)dehydrogenase 1 GGTCAGAAGAAACTCTCAAGAAGGTG GCGAAGGTCATGTCCTCCAT TCTTCAGCACACTACGTTG
GAPDH Glyceraldehyde-phosphate-dehydrogenase TTCGTCAAGCTCATTTCCTGGTA TCCTCGCGTGCTCTTGCT AATTTGGCTACAGCAACAG
ACTB Actin, beta CAAGGACCTCTACGCCAACAC TGGAGGCGCGATGATCTT CACCACCATGTACCCAGG
TBP TATA-box binding protein CAGAATGATCAAACCGAGAATTGT CTGCTCTGACTTTAGCACCTGTTAA TTTGTCTCTGGAAAAGTTGT
B2M Beta-2-microglobulin TCACTCCTAACGCTGTGGATCA CGGTTAGTGGTCTCGATCCC AGCACGTGACTCTCGATA
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